ALNY
ALNYLAM PHARMACEUTICALS, INC.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Mar 5 ▼ 2 insiders sell $542.8K at $324.08
- Apr 2 to Apr 6 ▼ 2 days of insider sells: $1.3M by 1 insider, avg $325.92
- Jun 1 ▼ 1 insider sell $1.1M at $299.18
- Jul 30 ▼ Alnylam reported Q2 2026 non-GAAP diluted EPS of $1.84 (missed conse…
- Aug 11 ▼ Cory Booker sold $1,001 - $15,000, last disclosed Sep 9
- Aug 17 The Board of Regents of the University of Texas System v…
- Aug 31 ▼ Short interest jumps 32.9% to 6.34M
- Oct 2 ▼ 1 insider sell $398.9K at $226.88
- Oct 29 ▲ Alnylam reported Q3 2026 total net product revenues of $1,292M, up 5…
- Oct 29 Trading halt: Halt Resumed: ALNY, trading resumed after LUDP (Volatility…
- Nov 2 ▼ Truist Securities downgrades
- Nov 9 to Nov 10 ▲ 2 days of insider buys: $543.1K by 2 insiders, avg $154.74
Signal stack
Where each data set points today.
- InsidersBEARISH
2 insiders bought $543.1K at an average $154.74. 5 insiders sold $3.4M.
- InstitutionsMIXED
Q3 2026: 56 added (1 new), 50 trimmed or exited. Largest new: Hrt Financial $10.6M.
- AnalystsBULLISH
29 of 38 rate it Buy or better. Every target is above the price.
- Short sellersCOVERING
Short interest −16.8% to 5.47M shares. 1.9 days to cover, ≈4.1% of shares.
- TrendDOWNTREND
26% below its 50-day average. New closing low $151.64 on Nov 10.
- SocialQUIET
Crowd 50° (neutral) this week from 1 mention: 0 bullish, 0 bearish. No setup is alerting.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| BAILLIE GIFFORD & CO | DOUBLED | $1.4B |
| JPMORGAN CHASE & CO | TRIM | $437.6M |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | ADD | $284.2M |
| AMERICAN CENTURY COMPANIES INC | TRIM | $249.2M |
| FIRST TRUST ADVISORS LP | ADD | $136.8M |
| Pictet Asset Management Holding SA | ADD | $122.8M |
| CITIGROUP INC | ADD | $80.8M |
| Hudson Bay Capital Management LP | ADD | $49.3M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
38 analystsPrice is below the lowest target. Median implies +87%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 2, 2026 | Barclays MAINTAIN | Overweight |
| Nov 2, 2026 | Truist Securities DOWNGRADE | Hold |
| Nov 2, 2026 | Canaccord Genuity MAINTAIN | Buy |
| Oct 30, 2026 | UBS MAINTAIN | Buy |
| Oct 30, 2026 | TD Cowen MAINTAIN | Buy |
| Oct 30, 2026 | Bernstein DOWNGRADE | Market Perform |
Washington
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Sigal Charles Elliott Director Nov 10, 2026 | BUY | $243.6K |
PYOTT DAVID E I Director Nov 10, 2026 | EXERCISE | $272.1K |
SCHULMAN AMY W Director Nov 9, 2026 | BUY | $299.5K |
SUPRAN BRYAN EVP, CLO and Secretary Oct 2, 2026 | SELL | $398.9K |
Greenstreet Yvonne Chief Executive Officer Sep 19, 2026 | AWARD | 107 sh |
PYOTT DAVID E I Director Jun 1, 2026 | SELL | $5.1K |
PYOTT DAVID E I Director Jun 1, 2026 | SELL | $148.9K |
PYOTT DAVID E I Director Jun 1, 2026 | SELL | $351.2K |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026| Oct 29, 2026 | Volatility Pause | Resumed |
SecBot reports
15 filings · 3 bullish · 2 bearish · 10 neutral- NEUTRAL SC 13GNov 16, 2026
T. Rowe Price Investment Management filed a Schedule 13G disclosing a 7.5% passive stake in Alnylam Pharmaceuticals as of September 30, 2026. This is a new passive disclosure by a large asset manager, adding to a series of routine 13G filings from major holders (Capital World, Fidelity, CRGI) over…
🔒 Fresh report (last 24h), subscribers only
- NEUTRAL SC 13G/ANov 13, 2026
Capital Research Global Investors (CRGI) filed an amended Schedule 13G disclosing a 8.2% passive…
Monitor for any further reductions by CRGI or other large passive holders. The decrease is modest and consistent with routine rebalancing; no immediate read-through for the stock.
- NEUTRAL SC 13G/ANov 13, 2026
Capital World Investors filed an amended Schedule 13G disclosing a 10.4% passive stake in Alnylam…
Monitor for any future conversion of this 13G to a 13D, which would signal a shift from passive to activist intent. For now, the filing is a routine passive stake update with no immediate trading…
- NEUTRAL CLUSTERNov 12, 2026
Two ALNY directors made open-market purchases totaling $543K at prices between $152 and $157 per…
The dollar amounts are immaterial relative to market cap and involve only board members, not operating executives. No immediate read-through for fundamentals. Monitor next 10-Q for any change in…
All ALNY filing & press-release reports (15)
- SC 13G reportNov 16, 2026
- SC 13G/A reportNov 13, 2026
- SC 13G/A reportNov 13, 2026
- CLUSTER reportNov 12, 2026
- SC 13G/A reportNov 5, 2026
- 8-K reportNov 5, 2026
- SC 13G reportOct 30, 2026
- 8-K reportOct 29, 2026
- INST-CLUSTER reportOct 23, 2026
- COURT-RULING reportAug 17, 2026
- 8-K reportJul 30, 2026
- INST-CLUSTER reportJul 28, 2026
- CLUSTER reportMar 3, 2026
- CLUSTER reportMar 3, 2026
- INST-CLUSTER reportFeb 28, 2026